Lost Money on Regencell Bioscience Holdings Limited (RGC)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
SueWallSt issued a press release soliciting shareholders of Regencell Bioscience Holdings (RGC) to join a class action lawsuit regarding alleged market manipulation and inadequate disclosures. The firm highlights that RGC achieved a $14 billion market cap despite having zero revenue and only 12 employees, while shares surged 48,650% before collapsing following a DOJ subpoena disclosure. The lead plaintiff deadline is June 23, 2026.
Key figures
- Surge pct
- 48,650%
- Market cap
- $14 billion
- Employee count
- 12
- Price drop pct
- 18.56%
- Price drop usd
- $3.09
- Rd spend annual
- $1 million
- Share price peak
- $78.00
- Share price close
- $13.56
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.